Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-09 @ 7:34 AM
Study NCT ID:
NCT02207504
Status:
COMPLETED
Last Update Posted:
2022-01-06
First Post:
2014-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08
Start Date Type:
None
Primary Completion Date:
2018-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-30
First Submit QC Date:
None
Study First Post Date:
2014-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-05
Last Update Post Date:
2022-01-06
Last Update Post Date Type:
ACTUAL